Fundraising Fox

Aron Szanto

Investor

Advisor Partner at Asymmetric Capital Partners

New York, New York, United States

About

Aron Szanto is Head of Technology at Redesign Health, where he leads technology innovation focused on healthcare. He has previously founded and led teams at OccamzRazor, PathAI, Kensho, Harvard, the Zerobase Foundation, and MarketFactory, working on problems in areas such as Parkinson's disease, cancer, misinformation, Covid-19, and machine learning.

Invests in

AI & Machine LearningHealthtech

Experience

  1. Redesign HealthHead of Technologycurrent2024 β€” presentNew York, United States
  2. AsymmetricAdvisor Partnercurrent2023 β€” presentNew York, United States
  3. OccamzRazorChief Technology Officer2023 β€” 2024New York, United States
  4. PathAIHead of Machine Learning Products2022 β€” 2023New York, United States
  5. Kensho TechnologiesGM, Machine Learning and Natural Language Processing2018 β€” 2022New York, United States
  6. Zerobase FoundationFounder and Chief Executive Officer2020 β€” 2021New York, United States
  7. Harvard UniversityAssociated Researcher, Department of Computer Science2018 β€” 2020Cambridge, Massachusetts, United States
  8. MarketFactoryProduct Engineering Manager2015 β€” 2018New York City Metropolitan Area
  9. R.G. Niederhoffer Capital ManagementSoftware Engineer2014 β€” 2015New York City Metropolitan Area

Education

  1. Harvard UniversityApplied Mathematics, Computational Economics and Machine Learning

Skills & more

Team ManagementTechnical Product ManagementMachine LearningArtificial IntelligenceDistributed SystemsDeep LearningMacroeconomicsBig Data AnalyticsFinancial AnalysisFutures TradingTime Series AnalysisHigh Frequency Trading
+12 moreFinancial ModelingMathematicsFunctional ProgrammingAgileScrumScikit-LearnArtificial Neural NetworksContact TracingKubernetesC++CPython

Languages Hungarian Β· Spanish

  • Series 3 Certification (National Commodity Futures Examination) β€” FINRA

From Aron's professional profile.

Same school

Shared employers

Colleagues at Asymmetric Capital Partners